Attendees joined Dr. Dae Hyun Kim for a discussion on the role of frailty in determining resilience, functional decline, and mortality risk in older adults, comparing conventional and emerging frailty assessment methods and their implications for clinical care, public health, and healthy aging.

Attendees joined Ankit Gupta, General Partner at Y Combinator, for a fireside chat on entrepreneurship at the intersection of AI and the life sciences, drawing from his experience building and scaling AI-driven biotech companies.

Attendees joined Dr. Charles A. Czeisler for a discussion on how light and circadian timing regulate sleep, alertness, and human physiology, alongside emerging research on sleep medications, dementia risk, all-cause mortality, and the broader implications of sleep health for brain aging and longevity.

Attendees got an inside look at how computational biology is transforming aging research from Harvard Medical School investigator and co-director of the Biomarkers of Aging Consortium, Mahdi Moqri, PhD and participated in a hands-on demo using Biolearn, an open-source toolkit for biomarkers of aging data analysis.

Attendees got an inside look at how computational biology is transforming aging research from Harvard Medical School investigator and co-director of the Biomarkers of Aging Consortium, Mahdi Moqri, PhD and participated in a hands-on demo using Biolearn, an open-source toolkit for biomarkers of aging data analysis.

CEO and Co-Founder Laura Deming, Head of Hardware John Bailey, and Chief Scientific Officer Hunter Davis, spoke about their work toward reversible cryopreservation for organ transplants and major milestones including a cryoprotective agent discovery engine, a custom electromagnet, and new cooling methods aimed at improving post-thaw organ function.

Dylan Livingston, who leads the Alliance for Longevity Initiatives (A4LI), the first U.S. nonprofit dedicated to advancing pro-longevity policies on Capitol Hill, spoke about translational aging policy and the new efforts in Washington that are shaping the future of aging research.

​This session of the "Inside Aging" Nucleate Thematic Series covered the role of ventures and startups in the longevity biotech space. ft. Lada Nuzhna, Alex Colville, PhD, and Steve Robinette, PhD, and Justin Olshavsky, PhD

​This session of the "Inside Aging" Nucleate Thematic Series focused on the use of aging clocks, omics technologies, and computational tools in aging research. ft. Steve Horvath, PhD, and Alan Tomusiak, PhD

In this "Inside Aging" Nucleate Thematic Series, Nir Barzilai, Joan Mannick, and Matt Kaeberlein discuss opportunities and necessary next steps for advancing therapeutics addressing the underlying mechanisms of aging as well as related physical and cognitive decline.

Participants learned from co-founders Laura Deming and Hunter Davis as well as members of the team discuss their story, progress thus far, and some of the most challenging outstanding technical problems.​ Participants also met and chat with team after presentation and Q&A.

This session of the "Inside Aging" Nucleate Thematic Series featured keynote speakers Eric Verdin and Martin Borch Jensen. This panel provided an overview of the aging biology field and the lanscape of longevity biotech. Viewers learned more about opportunities to get involved with this emergent space at the bench and beyond!